Rein Therapeutics RNTX
NASDAQ RNTX
$0.85 +0.05 (+5.98%)
At close: Oct 1, 2026 · 4:00 PM EDT

Rein Therapeutics (RNTX) Return on Equity [ROE] (2017 - 2026)

Updated

Rein Therapeutics (RNTX) posted Return on Equity [ROE] of -148.09% for Q2 2026, down 22.75 percentage points from -125.34% a year earlier but up 204.45 percentage points from the prior quarter.

Analysis

Rein Therapeutics (RNTX) Return on Equity [ROE] (2017 - 2026) Analysis & Trends

For FY2025, Rein Therapeutics' Return on Equity [ROE] came in at -140.01%, down 56.74 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of +5.30 percentage points (FY2020 to FY2025).
  • In prior years, Rein Therapeutics' Return on Equity [ROE] was -83.26% in FY2024 (-55.42 pp), -27.84% in FY2023 (+60.59 pp), -88.43% in FY2022 (+6.47 pp) and -94.91% in FY2021 (+50.40 pp).
  • Quarterly Return on Equity [ROE] has run from a low of -352.53% in Q1 2026 to a high of -19.48% in Q1 2024 over five years.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last seven quarters, with an average year-over-year change of -75.03 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2024, with a gain of 127.88 percentage points; the weakest was Q1 2026, with a drop of 230.71 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -352.53% (Q1 2026), -160.46% (Q4 2025) and -129.02% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Rein Therapeutics 53.67 Mn 53.67 Mn - -148.09%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -148.09%
Mar 31, 2026 -352.53%
Dec 31, 2025 -160.46%
Sep 30, 2025 -129.02%
Jun 30, 2025 -125.34%
Mar 31, 2025 -121.83%
Dec 31, 2024 -87.03%
Sep 30, 2024 -30.17%
Jun 30, 2024 -26.53%
Mar 31, 2024 -19.48%
Dec 31, 2023 -29.73%
Sep 30, 2023 -114.11%
Jun 30, 2023 -134.39%
Mar 31, 2023 -147.36%
Dec 31, 2022 -133.82%
Sep 30, 2022 -115.99%
Jun 30, 2022 -92.91%
Mar 31, 2022 -70.08%
Dec 31, 2021 -56.60%
Sep 30, 2021 -45.15%
API Access

Rein Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RNTX&period=max&api_key=YOUR_API_KEY